Safety, Tolerability, Efficacy of EA0010 in OTOF Patients With CI
Clinical trial NCT07752888 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07752888
- Sponsor
- Shanghai EmayGene Technology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-23
- Primary completion
- 2027-05-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.